# NAYZILAM
> **NDA211321** · New Drug Application · Sponsor: UCB INC · Approved 2019-05-17
## Drug
- **FDA Application Number:** NDA211321
- **Application type:** New Drug Application
- **Brand name:** NAYZILAM
- **Generic name:** MIDAZOLAM
- **Active ingredients:** MIDAZOLAM
- **Dosage form:** SPRAY
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** UCB INC
- **Manufacturer:** UCB, Inc.
- **First approval:** 2019-05-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211321)
---
*AI Analytics · CC0 1.0*